Dr Reddy's recalls around 70,000 vials of Zoledronic acid injection from US

The vials were manufactured by Gland Pharma for Dr Reddy's Laboratories, the Enforcement Report said.

Published: 03rd October 2018 03:33 PM  |   Last Updated: 03rd October 2018 03:33 PM   |  A+A-

A Dr Reddy's Laboratory outlet (Photo | Twitter)

By PTI

NEW DELHI: The US arm of drug firm Dr Reddy's Laboratories is recalling around 70,000 vials of Zoledronic acid injection manufactured by Gland Pharma from the US market, the latest report of the US health regulator has said.

Dr Reddy's Laboratories Inc is "recalling 59,468 vials of Zoledronic acid injection, 5mg/100 mL (0.05 mg/mL) 100ml vial," Enforcement Report of the United States Food and Drug Administration (USFDA) said.

READ| Dr Reddy's launches Hervycta to treat cancer in India 

The company is also recalling 10,530 vials of Zoledronic acid injection, 5 mg/100 mL (0. 05 mg/mL) one 100ml single-dose bottle, it added.

The vials are being recalled on account of "Out-of-specification result observed for related substance: unknown impurity," the report said.

The product was distributed to retailers, distributors, physician officers and medical facilities throughout the United States, it added.

The vials were manufactured by Gland Pharma for Dr Reddy's Laboratories, the Enforcement Report said.

As per the USFDA "all recalls monitored by FDA are included in the Enforcement Report once they are classified and may be listed prior to classification when FDA determines the firm's removal or correction of a marketed product(s) meets the definition of a recall.

Stay up to date on all the latest Business news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp